US equities |
MU $919.02 ▲+0.54% NVDA $218.18 ▼-1.41% SNDK $1,364.90 ▼-2.74% SPCX $148.27 ▼-2.56% AMD $562.22 ▼-1.51% INTC $95.60 ▼-2.57% AAPL $343.02 ▲+0.02% CRWV $68.58 ▲+4.26%
FinancialContent

Latest News about Philip Young

Recent news which mentions Philip Young

Psychedelics Funding At Its Best: $1.5 M Destined To Psilocybin Clinical Trials In Australia
Tickers ATAI DRUG LOBEF
Tags Cantheon Capital Global Management
From Benzinga
This Psychedelic Company Just Signed An Exclusive Deal For Psilocin Clinical Trials In Australia
Tickers LOBEF
Tags Markets Dr/ Sud Agarwal iNGENū
From Benzinga
Two Psychedelic Companies File Patent Applications For Psilocybin And MDMA Analogues, Here's What Could Change
Tickers LOBEF MYCOF
Tags Penny Stocks MYCOF Rob Roscow
From Benzinga